Vitamin K2 reduces the frequency, intensity, and duration of nighttime leg cramps

Once con­sid­ered a niche can­cer ther­a­py, ra­di­oli­gands are in the midst of a re­nais­sance. “If you think about where AD­Cs were four or five years

Boehringer In­gel­heim is build­ing on its col­lab­o­ra­tion with OSE Im­munother­a­peu­tics by in­ves­ti­gat­ing two clin­i­cal-stage on­col­o­gy pro­grams in car­dio-re­nal-meta­bol­ic dis­ease and adding a third pre­clin­i­cal can­cer

A pri­vate start­up from Salt Lake City aim­ing to de­vel­op oral an­ti­bod­ies says it has suc­ceed­ed in an ear­ly tri­al, a po­ten­tial­ly sig­nif­i­cant sci­en­tif­ic ad­vance­ment